Genetic biomarkers associated with pain flare and dexamethasone response following palliative radiotherapy in patients with painful bone metastases
- PMID: 29156912
- DOI: 10.21037/apm.2017.09.04
Genetic biomarkers associated with pain flare and dexamethasone response following palliative radiotherapy in patients with painful bone metastases
Abstract
Background: In patients who receive palliative radiation therapy (RT) for painful bone metastases, 40% experience a transient increase in pain known as a pain flare. Prophylactic dexamethasone has been shown to reduce pain flare incidence to 25%. We aimed to identify DNA biomarkers associated with pain flare and dexamethasone response.
Methods: Daily pain levels were recorded by 81 patients who received a single 8 Gy RT for painful bone metastases, of which 50 also received prophylactic dexamethasone. To identify single-nucleotide variants (SNVs), patient saliva samples obtained at day of RT were sequenced for 4,813 disease-associated genes, then filtered for genes associated with inflammation, radiation or immune response, and DNA damage. Significant SNVs (P<0.005) identified by the Cochran-Armitage trend test underwent the Penalized LASSO method with minimum Bayesian Information Criterion to select a multi-SNV model that jointly predicted pain flare, and pain flare despite prophylactic dexamethasone (dexamethasone response). The corresponding estimated effects of the multi-SNVs were used to drive the prognostic score of developing pain flare for each patient, who were divided into three risk groups of roughly equal sizes.
Results: Risk groups were significantly predictive of pain flare (P<0.0001) and dexamethasone response (P<0.0001). The high-risk patient groups had a 78% chance of developing pain flare, and pain flare despite dexamethasone [OR =24.6, 95% confidence interval (CI): 1.8-342.7, P=0.02]. The multivariable model for pain flare included 15 variants, with effect sizes ranging from -4.97 (NBPF1 rs3872309 C>T) to 5.54 (DNM2 10940838 A>C). The multivariable model for dexamethasone response included 6 variants, with effect sizes ranging from -1.03 (NBPF1 rs3872309 C>T) to 0.85 (TSEN54 rs62088470 C>G).
Conclusions: Significant SNVs associated with pain flare were found in genes with functions in biosynthesis (DHODH, PECR), lipid excretion and metabolism (UGT2A1/2, VLDLR), and intracellular signalling (DNM2, SEC23A). Significant SNVs associated with dexamethasone response were from genes involved in extracellular matrix (HAS1, ADAMTS16) and cytoskeleton regulation (GAS2L2). Identification of SNVs predictive of pain flare and dexamethasone response enables targeted prophylactic therapy according to a patient's predisposed response.
Keywords: Genetic biomarker; dexamethasone; pain flare; palliative radiotherapy; single nucleotide variant.
Similar articles
-
Genetic biomarkers associated with changes in quality of life and pain following palliative radiotherapy in patients with bone metastases.Ann Palliat Med. 2017 Dec;6(Suppl 2):S248-S256. doi: 10.21037/apm.2017.09.01. Epub 2017 Sep 28. Ann Palliat Med. 2017. PMID: 29156910 Clinical Trial.
-
Genetic biomarkers associated with response to palliative radiotherapy in patients with painful bone metastases.Ann Palliat Med. 2017 Dec;6(Suppl 2):S233-S239. doi: 10.21037/apm.2017.09.03. Epub 2017 Oct 10. Ann Palliat Med. 2017. PMID: 29156909 Clinical Trial.
-
Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.Lancet Oncol. 2015 Nov;16(15):1463-1472. doi: 10.1016/S1470-2045(15)00199-0. Epub 2015 Oct 18. Lancet Oncol. 2015. PMID: 26489389 Clinical Trial.
-
Pain Flare-Effect Prophylaxis With Corticosteroids on Bone Radiotherapy Treatment: A Systematic Review.Pain Pract. 2020 Jan;20(1):101-109. doi: 10.1111/papr.12823. Epub 2019 Sep 15. Pain Pract. 2020. PMID: 31342618
-
Latest advances in the management of radiation-induced pain flare, nausea and vomiting.Ann Palliat Med. 2016 Jan;5(1):50-7. doi: 10.3978/j.issn.2224-5820.2015.08.01. Ann Palliat Med. 2016. PMID: 26841815 Review.
Cited by
-
A Scalable Radiomics- and Natural Language Processing-Based Machine Learning Pipeline to Distinguish Between Painful and Painless Thoracic Spinal Bone Metastases: Retrospective Algorithm Development and Validation Study.JMIR AI. 2023 May 22;2:e44779. doi: 10.2196/44779. JMIR AI. 2023. PMID: 38875572 Free PMC article.
-
The Functional Role of SEC23 in Vesicle Transportation, Autophagy and Cancer.Int J Biol Sci. 2019 Sep 7;15(11):2419-2426. doi: 10.7150/ijbs.37008. eCollection 2019. Int J Biol Sci. 2019. PMID: 31595159 Free PMC article. Review.
-
Personalized Radiation Therapy in Cancer Pain Management.Cancers (Basel). 2019 Mar 19;11(3):390. doi: 10.3390/cancers11030390. Cancers (Basel). 2019. PMID: 30893954 Free PMC article. Review.
-
Growth arrest-specific 2 protein family: Structure and function.Cell Prolif. 2021 Jan;54(1):e12934. doi: 10.1111/cpr.12934. Epub 2020 Oct 25. Cell Prolif. 2021. PMID: 33103301 Free PMC article. Review.
-
Deep sequencing analysis to identify novel and rare variants in pain-related genes in patients with acute postoperative pain and high morphine use.J Pain Res. 2019 Sep 19;12:2755-2770. doi: 10.2147/JPR.S213869. eCollection 2019. J Pain Res. 2019. PMID: 31571979 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical